MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.02.2026
Thermo Fisher Scientific Gesamtverbindlichkeiten 2011-2026 | TMO
Gesamtverbindlichkeiten Jährlich Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 28.7 B | 28.6 B | 31.3 B | 24.4 B | 19.5 B | 22.3 B | 15 B | 12 B | 11.8 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 31.3 B | 11.8 B | 21.5 B |
Gesamtverbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
107 M | $ 18.89 | -3.13 % | $ 581 M | USA |
 |
Celcuity
CELC
|
366 M | $ 89.34 | -3.39 % | $ 4.18 B | USA |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
4.11 M | $ 5.63 | -2.34 % | $ 7.49 M | USA |
 |
Castle Biosciences
CSTL
|
108 M | $ 21.25 | -1.62 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
84.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
2.11 B | $ 128.77 | -3.22 % | $ 16.1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
110 M | $ 22.6 | -2.25 % | $ 1.2 B | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
7.08 B | $ 149.81 | -1.96 % | $ 11.7 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
11.5 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
Illumina
ILMN
|
2.7 B | $ 162.31 | -3.42 % | $ 25.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.36 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 103.33 | 0.5 % | $ 6.97 B | USA |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 185.1 | -0.37 % | $ 9.17 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 454.92 | -0.82 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
3.74 B | $ 1 162.75 | -1.5 % | $ 24 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
523 M | $ 11.12 | -1.68 % | $ 1.42 B | USA |
 |
National Research Corporation
NRC
|
121 M | $ 19.87 | 0.61 % | $ 445 M | USA |
 |
Myriad Genetics
MYGN
|
339 M | $ 4.66 | -0.75 % | $ 432 M | USA |
 |
Natera
NTRA
|
686 M | $ 217.81 | -1.93 % | $ 29.8 B | USA |
 |
Personalis
PSNL
|
73 M | $ 11.27 | -6.83 % | $ 1.01 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
16 B | $ 26.17 | 0.69 % | $ 24.8 B |  Niderland |
 |
Senseonics Holdings
SENS
|
65.2 M | $ 6.83 | -2.57 % | $ 285 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
114 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.22 | 3.27 % | $ 5.1 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 265.1 | 1.58 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
169 M | $ 71.05 | -3.9 % | $ 4.25 B | USA |
 |
Trinity Biotech plc
TRIB
|
138 M | $ 0.71 | 3.79 % | $ 255 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
1.37 B | $ 8.93 | -2.14 % | $ 1.94 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 199.14 | 1.54 % | $ 22.1 B | USA |
 |
Invitae Corporation
NVTA
|
1.85 B | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
2.52 B | $ 369.99 | -1.72 % | $ 22 B | USA |